Micronova
Sterilisation Solutions for Pharmaceutical Manufacturing
SuperNova Diagnostics has entered into a commercial partnership with European specialist healthcare distributor Concile to develop the point-of-care diagnostic test for assessing wellness deficiencies.
SuperNova Diagnostics has entered into a commercial partnership with European specialist healthcare distributor Concile to develop the point-of-care diagnostic test for assessing wellness deficiencies.
SuperNova will create and manufacture the point-of-care test product, secure regulatory approvals and co-promote the product in the European market.
SuperNova will retain 100% of marketing rights outside of the EU and has the ability to sub-licence or sell directly.
Concile sells and develops diagnostic products for cardiovascular, oncology, wellness, infectious disease, diabetes, metabolic and esoteric diseases.
Sterilisation Solutions for Pharmaceutical Manufacturing
Turn Key Cleanroom Systems from Planning to Qualification
Medical Device Sterilisation